1. Home
  2. SILO vs SOBR Comparison

SILO vs SOBR Comparison

Compare SILO & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • SOBR
  • Stock Information
  • Founded
  • SILO 2010
  • SOBR 2004
  • Country
  • SILO United States
  • SOBR United States
  • Employees
  • SILO N/A
  • SOBR N/A
  • Industry
  • SILO Apparel
  • SOBR Newspapers/Magazines
  • Sector
  • SILO Consumer Discretionary
  • SOBR Consumer Discretionary
  • Exchange
  • SILO Nasdaq
  • SOBR Nasdaq
  • Market Cap
  • SILO 5.9M
  • SOBR 4.9M
  • IPO Year
  • SILO N/A
  • SOBR N/A
  • Fundamental
  • Price
  • SILO $0.70
  • SOBR $3.25
  • Analyst Decision
  • SILO
  • SOBR
  • Analyst Count
  • SILO 0
  • SOBR 0
  • Target Price
  • SILO N/A
  • SOBR N/A
  • AVG Volume (30 Days)
  • SILO 948.9K
  • SOBR 14.5K
  • Earning Date
  • SILO 11-11-2025
  • SOBR 11-13-2025
  • Dividend Yield
  • SILO N/A
  • SOBR N/A
  • EPS Growth
  • SILO N/A
  • SOBR N/A
  • EPS
  • SILO N/A
  • SOBR N/A
  • Revenue
  • SILO $72,102.00
  • SOBR $301,400.00
  • Revenue This Year
  • SILO $1.86
  • SOBR N/A
  • Revenue Next Year
  • SILO N/A
  • SOBR N/A
  • P/E Ratio
  • SILO N/A
  • SOBR N/A
  • Revenue Growth
  • SILO N/A
  • SOBR 73.21
  • 52 Week Low
  • SILO $0.41
  • SOBR $2.41
  • 52 Week High
  • SILO $3.37
  • SOBR $193.50
  • Technical
  • Relative Strength Index (RSI)
  • SILO 53.25
  • SOBR 45.21
  • Support Level
  • SILO $0.58
  • SOBR $3.08
  • Resistance Level
  • SILO $0.83
  • SOBR $3.31
  • Average True Range (ATR)
  • SILO 0.05
  • SOBR 0.20
  • MACD
  • SILO 0.01
  • SOBR 0.01
  • Stochastic Oscillator
  • SILO 45.56
  • SOBR 52.94

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About SOBR SOBR Safe Inc.

Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.

Share on Social Networks: